Particle.news
Download on the App Store

Robbie Williams Blames Weight-Loss Injections for Worsening Vision, Plans to Continue Treatment

Medical evidence on tirzepatide‑related vision risk remains unsettled despite warnings tied to semaglutide.

Overview

  • Williams, 51, told The Sun his eyesight has progressively blurred and he now struggles to see faces on stage and even players at a football game.
  • He said an optician prescribed new lenses after he initially failed to mention the injections because he had not connected them to his symptoms.
  • The singer intends to keep using the shots and urged others to research potential risks, citing major mental‑health benefits from the therapy.
  • Reports identify his medication as Mounjaro (tirzepatide) and note he has lost more than 20 kilograms over two years, alongside periods of very low food intake and a scurvy diagnosis earlier this year.
  • Regulators and researchers have linked semaglutide drugs to rare eye disorders and the EMA listed vision problems as a possible side effect in June 2025, but experts say data are limited for tirzepatide and the size of any risk remains disputed.